Saltar al contenido
Merck

Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

Molecular pharmacology (1998-03-14)
R M Krause, B Buisson, S Bertrand, P J Corringer, J L Galzi, J P Changeux, D Bertrand
RESUMEN

We report that preapplication of ivermectin, in the micromolar range, strongly enhances the subsequent acetylcholine-evoked current of the neuronal chick or human alpha7 nicotinic acetylcholine receptors reconstituted in Xenopus laevis oocytes and K-28 cells. This potentiation does not result from nonspecific Cl- currents. The concomitant increase in apparent affinity and cooperativity of the dose-response curve suggest that ivermectin acts as a positive allosteric effector. This interpretation is supported by the observation of an increase in efficiency of a partial agonist associated with the potentiation and by the differential effect of ivermectin on mutants within the M2 channel domain. Ivermectin effects reveal a novel allosteric site for pharmacological agents on neuronal alpha7 nicotinic acetylcholine receptors.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ivermectin